• Difloxacin HCl: Assay Workflows and Use Cases

  2026-09-10

  Difloxacin HCl supports two distinct research paths: bacterial DNA replication inhibition for antimicrobial susceptibility testing and exploratory multidrug resistance reversal through MRP substrate sensitization. This practical guide covers formulation, controls, workflow design, checkpoint-biology context, and troubleshooting without treating research results as clinical recommendations.

• Thymoquinone in Doxorubicin Cardiotoxicity Models

  2026-09-10

  Thymoquinone offers a practical probe for connecting cardiac function, oxidative stress, mitochondrial injury, and ferroptosis in doxorubicin models. This workflow translates recent mouse findings into formulation controls, orthogonal assays, and troubleshooting steps for more reproducible cardioprotection studies.

• From Bile-Acid Subtypes to qPCR Biomarkers

  2026-09-09

  A translational analysis of how bile acid metabolism signatures in colorectal cancer can be converted into reproducible qPCR biomarkers using robust reverse transcription, genomic DNA contamination control, and disciplined validation.

• Peptidisc-Assisted Nanobody Clustering: Study Insights

  2026-09-09

  This bioRxiv preprint describes a peptidisc-assisted strategy for clustering nanobodies through hydrophobic transmembrane segments, producing multimeric assemblies called polybodies. The reported avidity gains, bispecific assemblies, and autofluorescent constructs suggest a flexible route to multifunctional binders, while the preprint status and limited quantitative detail require careful validation.

• SB 225002 and the CXCR2–IL-8 Decision Point

  2026-09-08

  The IL-8 axis is not a single pathway: receptor usage can separate tumor-cell proliferation from neutrophil trafficking. This thought-leadership analysis positions SB 225002 as a selective CXCR2 tool for testing that distinction in inflammation, cancer, and infection-associated microenvironment models.

• Phosphatase Inhibitor Cocktail 1 Workflow

  2026-09-07

  Protect labile phosphorylation states from cell harvest through Western blotting, co-immunoprecipitation, and phosphoproteomic analysis. This workflow combines a practical 1X starting condition with tissue-panel guidance inspired by UPF3A expression research, while highlighting controls and troubleshooting limits.

• Pifithrin-α: Practical p53 Inhibition Workflows

  2026-09-07

  Pifithrin-α provides a reversible way to test whether DNA damage, deltamethrin stress, ferroptosis, or irradiation phenotypes depend on p53 signaling. This guide translates a recent maternal neurotoxicity study into practical cell-based workflows, formulation advice, controls, and troubleshooting strategies.

• EdU Imaging Kits: Reading S-Phase in RCC

  2026-09-05

  EdU Imaging Kits (HF488) provide a precise way to interpret DNA synthesis in renal cell carcinoma models. This article connects EdU click chemistry with the esculin RCC study and offers a practical framework for microscopy, flow cytometry, and orthogonal validation.

• PPT and ERα: From Selective Signal to Translation

  2026-09-05

  PPT (Propyl Pyrazole Triol) provides a precise way to perturb ERα while minimizing ERβ-driven ambiguity. This thought-leadership article connects its receptor-level pharmacology with the FOXM1–ERα network reported in female lung adenocarcinoma and offers a practical framework for translational validation.

• Cyclic di-GMP: From Signal to Assay Design

  2026-09-04

  Cyclic di-GMP is an intracellular second messenger linking bacterial persistence biology with STING-centered immune modulation research. This article focuses on stage-resolved assay design, causal interpretation, and the practical limits of translating bacterial findings into cancer immunotherapy studies.

• Z-VEID-FMK: Caspase-6 Inhibitor Workflow

  2026-09-04

  Z-VEID-FMK is a cell-permeable, irreversible caspase-6 inhibitor for separating caspase-6-dependent proteolysis from broader apoptotic effects. This workflow connects practical apoptosis assays with a viral immune-evasion model involving PRRSV N-protein cleavage, while emphasizing controls, timing, and interpretation.

• V5 Epitope Tag Peptide: Workflow Guide

  2026-09-03

  Build more reliable recombinant-protein detection workflows with the V5 Epitope Tag Peptide as a sequence-specific competition control, assay calibrator, and purification aid. The guide connects routine Western blotting and immunoprecipitation with antibody-kinetic insights from single-molecule microscopy, while emphasizing practical controls and troubleshooting.

• Dual Luciferase Reporter Gene System for BMSC Studies

  2026-09-02

  Apply the Dual Luciferase Reporter Gene System to separate pathway-dependent transcriptional effects from sample-to-sample variability in BMSC research. This workflow combines firefly/Renilla normalization, no-lysis mammalian cell detection, and practical controls for studying MRF–FSHR–cAMP-PKA-CREB regulation.

• SAR131675: A VEGFR-3 Assay Strategy

  2026-09-02

  Explore SAR131675, a selective VEGFR-3 inhibitor, through a practical framework linking kinase selectivity, endothelial phenotypes, and the VEGFC–macrophage axis in hepatic fibrosis research.

• KN-62: Designing Causal Calcium Signaling Assays

  2026-09-02

  KN-62 is a selective CaMKII inhibitor for separating kinase-dependent signaling from direct calcium-channel effects. This guide builds a causal assay framework from neuronal channel pharmacology, with practical guidance for secretion, metabolism, and cell-cycle studies.

8461 records 1/565 page Next 12345 下5页 Last page